Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

PRESIDENT & COO

SVP & CHIEF FINANCIAL OFFICER

CHAIRMAN & CEO

CHIEF DEVELOPMENT OFFICER

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the tr...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-10	Premium	acquired	Premium	Premium	Premium	-
2024-04-08	Premium	acquired	Premium	Premium	Premium	PRESIDENT & COO
2024-04-08	Premium	sold	Premium	Premium	Premium	PRESIDENT & COO
2024-04-08	Premium	sold	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-04-05	Premium	acquired	Premium	Premium	Premium	PRESIDENT & COO
2024-04-05	Premium	sold	Premium	Premium	Premium	PRESIDENT & COO
2024-04-05	Premium	sold	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-04-04	Premium	sold	Premium	Premium	Premium	PRESIDENT & COO
2024-04-04	Premium	sold	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-04-04	Premium	acquired	Premium	Premium	Premium	PRESIDENT & COO
2024-04-03	Premium	sold	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-04-03	Premium	sold	Premium	Premium	Premium	PRESIDENT & COO
2024-04-03	Premium	acquired	Premium	Premium	Premium	PRESIDENT & COO
2024-04-02	Premium	sold	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	CHAIRMAN & CEO
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT & COO
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF DEVELOPMENT OFFICER
2024-03-28	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT & COO
2024-03-28	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF DEVELOPMENT OFFICER
2024-03-28	Premium	sold (taxes)	Premium	Premium	Premium	CHAIRMAN & CEO
2024-03-28	Premium	sold (taxes)	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-03-25	Premium	sold (taxes)	Premium	Premium	Premium	CHAIRMAN & CEO
2024-03-25	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF DEVELOPMENT OFFICER
2024-03-14	Premium	acquired	Premium	Premium	Premium	PRESIDENT & COO

GKOS - Glaukos Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for GKOS